Want to see SE:MSON.B full AI Analyst Report?
Top Page
Midsona AB Class B
(MSON.B)
Select Model
Select Model
Rating:63Neutral
Price Target:
kr13.50
▲(51.69% Upside)
Action:Reiterated
Date:07/18/26
The score is driven primarily by improving financial performance—better margins, renewed revenue growth, and a de-risked balance sheet—tempered by still-thin profitability and a history of volatility. Technicals are a secondary drag with the stock below key short/mid-term moving averages, though oversold signals suggest selling pressure may be stretched. Valuation is only moderately supportive given a ~21.4 P/E and a modest ~1.74% dividend yield.
Positive Factors
Revenue and margin recovery
Sustained revenue growth and meaningful margin recovery indicate improving core operating performance and better cost absorption. That combination supports durable cash generation and pricing/mix resilience in its health-focused product portfolio over the next several months.
Negative Factors
Thin profitability
Net margins and return on equity remain modest despite improvement, constraining the company's ability to generate high incremental returns on invested capital. Low profitability limits capacity to self-fund faster growth or deliver material shareholder returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and margin recovery
Sustained revenue growth and meaningful margin recovery indicate improving core operating performance and better cost absorption. That combination supports durable cash generation and pricing/mix resilience in its health-focused product portfolio over the next several months.
Read all positive factors
Midsona AB Class B (MSON.B) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr2.07B
Dividend Yield2.34%
Average Volume (3M)58.03K
Price to Earnings (P/E)21.4
Beta (1Y)0.24
Revenue Growth-2.47%
EPS Growth460.15%
CountrySE
Employees688
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.77
Shares Outstanding145,004,300
10 Day Avg. Volume108,684
30 Day Avg. Volume58,033
Financial Highlights & Ratios
PEG Ratio-1.57
Price to Book (P/B)0.42
Price to Sales (P/S)0.34
P/FCF Ratio6.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.99
Revenue Forecast (FY)kr3.74B
Midsona AB Class B Business Overview & Revenue Model
Company Description
Midsona AB (publ) is a Swedish company that specializes in the development, manufacturing, and distribution of organic, health-focused, and consumer wellness products. Its operational footprint spans across several European nations, including Swed...
How the Company Makes Money
Midsona makes money primarily by selling branded health and wellness consumer products. Its revenue model is based on (1) wholesale sales to grocery chains, specialty retailers, and other trade customers, where Midsona supplies finished packaged g...
Midsona AB Class B Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
72
Positive
Cash Flow
66
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.59B | 3.63B | 3.73B | 3.79B | 3.90B | 3.77B |
| Gross Profit | 1.04B | 1.03B | 1.07B | 959.00M | 878.00M | 1.01B |
| EBITDA | 311.00M | 206.00M | 285.00M | 183.00M | -306.00M | 309.00M |
| Net Income | 112.00M | 10.00M | 47.00M | -53.00M | -501.00M | 89.00M |
Balance Sheet | ||||||
| Total Assets | 4.49B | 4.39B | 4.54B | 4.60B | 4.90B | 5.29B |
| Cash, Cash Equivalents and Short-Term Investments | 282.00M | 316.00M | 141.00M | 235.00M | 121.00M | 53.00M |
| Total Debt | 0.00 | 615.00M | 592.00M | 731.00M | 895.00M | 1.49B |
| Total Liabilities | 1.42B | 1.46B | 1.47B | 1.61B | 1.82B | 2.41B |
| Stockholders Equity | 3.07B | 2.93B | 3.07B | 2.99B | 3.08B | 2.88B |
Cash Flow | ||||||
| Free Cash Flow | 195.00M | 201.00M | 118.00M | 312.00M | 168.00M | -123.00M |
| Operating Cash Flow | 245.00M | 229.00M | 142.00M | 343.00M | 203.00M | -64.00M |
| Investing Cash Flow | -42.00M | -22.00M | -25.00M | -18.00M | -29.00M | -175.00M |
| Financing Cash Flow | -96.00M | -29.00M | -206.00M | -209.00M | -108.00M | 94.00M |
Midsona AB Class B Technical Analysis
Negative
8.90
Price Trends
13.98
Negative
12.97
Negative
10.82
Positive
Market Momentum
<0.01
Positive
28.78
Positive
19.22
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:MSON.B, the sentiment is Negative. The current price of 8.9 is below the 20-day moving average (MA) of 14.34, below the 50-day MA of 13.98, and below the 200-day MA of 10.82, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 28.78 is Positive, neither overbought nor oversold. The STOCH value of 19.22 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:MSON.B.
Midsona AB Class B Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | kr444.77M | 16.64 | ― | 0.51% | 24.64% | 136.01% | |
63 Neutral | kr2.07B | 21.44 | -0.17% | 2.34% | -2.47% | 460.15% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | kr561.00M | 46.79 | ― | 2.43% | -10.22% | -19.59% | |
54 Neutral | kr2.90B | 86.92 | 0.87% | ― | 3.21% | -722.98% | |
52 Neutral | kr75.58M | 28.14 | ― | ― | 0.20% | ― |
* Consumer Defensive Sector Average
SE:MSON.B
Midsona AB Class B
12.65
4.50
55.12%
SE:HUMBLE
Humble Group AB
6.18
-1.62
-20.77%
SE:NNH
New Nordic Healthbrands AB
12.10
-8.56
-41.44%
SE:SKMO
Skane-moellan AB
51.00
-18.56
-26.69%
SE:SNX
Premium Snacks Nordic AB
32.45
3.94
13.82%
Midsona AB Class B Corporate Events
Midsona Lifts Margins and Bets on Brands as Risenta Deal Closes
Jul 17, 2026
Midsona reported modest second-quarter net sales growth to SEK 870 million, but achieved a notable improvement in margins and operating profit thanks to better pricing, a more profitable product mix and ongoing cost savings. Its own consumer brand...
Midsona Schedules Presentation of January–June 2026 Interim Results
Jul 2, 2026
Midsona AB, a Nasdaq Stockholm-listed company, develops and markets health and well-being brands designed to support healthier and more sustainable lifestyles, emphasizing transparency about raw material origins and product contents. The groupR...
Midsona Completes Acquisition of Swedish Healthy Foods Brand Risenta
Jun 1, 2026
Midsona AB has completed the acquisition of the Risenta brand and finished-goods inventory from Paulig, integrating the deal through its subsidiaries Santa Maria AB and Midsona Sverige AB. Risenta, a well-established Swedish healthy foods brand wi...
Midsona AGM Approves Dividend, Share Issue Mandate and New Incentive Plan
May 6, 2026
Midsona AB’s annual general meeting in Malmö approved the 2025 financial statements and granted discharge from liability to the board and CEO, underscoring confidence in the group’s governance and performance. Shareholders backed ...
Midsona lifts margins, strengthens balance sheet and buys Risenta in Q1 2026 push for profitable growth
Apr 24, 2026
Midsona reported first-quarter 2026 net sales of SEK 893 million, down 4.7 percent year-on-year, but improved its gross margin to 29.8 percent and lifted operating profit before items affecting comparability to SEK 45 million. The company’s ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.